Soleno Therapeutics (SLNO) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 109.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.40% |
| Dec 31, 2025 | 92.34% |
| Sep 30, 2025 | 86.83% |
| Jun 30, 2025 | 80.99% |
| Mar 31, 2025 | 85.74% |
| Dec 31, 2024 | 77.96% |
| Sep 30, 2024 | 96.08% |
| Jun 30, 2024 | -11.05% |
| Mar 31, 2024 | 10.52% |
| Dec 31, 2023 | -14.20% |
| Sep 30, 2023 | -9.14% |
| Jun 30, 2023 | 3.78% |
| Mar 31, 2023 | 5.01% |
| Dec 31, 2022 | 5.73% |
| Sep 30, 2022 | -20.63% |
| Jun 30, 2022 | 8.37% |
| Mar 31, 2022 | 12.43% |
| Dec 31, 2021 | 40.10% |
| Sep 30, 2021 | 22.92% |
| Jun 30, 2021 | 27.59% |
| Mar 31, 2021 | 5.57% |
| Dec 31, 2020 | -6.17% |
| Sep 30, 2020 | -28.62% |
| Jun 30, 2020 | -31.55% |
| Mar 31, 2020 | -41.10% |
| Dec 31, 2019 | -19.40% |
| Sep 30, 2019 | -26.53% |
| Jun 30, 2019 | -42.87% |
| Mar 31, 2019 | -46.05% |
| Dec 31, 2018 | -48.08% |
| Sep 30, 2018 | -47.72% |
| Jun 30, 2018 | -32.88% |
| Mar 31, 2018 | -27.17% |
| Dec 31, 2017 | -26.37% |
| Sep 30, 2017 | 15.17% |
| Dec 31, 2016 | -12.70% |